"a little of what you fancy does you good, but a lot might not!" the discussion of supplementation continues.

Recently in discussion with a client, I happened to use the term Parkinson's disease - what happened next got me thinking…

Up until now, the PV database space has been dominated by well-known corporations, but PV trends are beginning to tell a different story.

Explore historical incidents and recent global alerts to reveal the persistent issue of adulterated drugs.

Whilst there is an attractiveness in using AI tools, there is also a growing concern on their potential for misuse. Is AI safety ready?

CSA & CSV share many values, but it is their differences that will help you to decide which is best adopted by your organisation.